nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—lung cancer	0.257	0.656	CbGaD
Fluphenazine—ABCB1—lung cancer	0.135	0.344	CbGaD
Fluphenazine—ABCB1—Topotecan—lung cancer	0.024	0.0841	CbGbCtD
Fluphenazine—ABCB1—Gefitinib—lung cancer	0.022	0.0769	CbGbCtD
Fluphenazine—CYP2D6—Gefitinib—lung cancer	0.0207	0.0725	CbGbCtD
Fluphenazine—CYP2E1—Etoposide—lung cancer	0.0186	0.065	CbGbCtD
Fluphenazine—ABCB1—Vinorelbine—lung cancer	0.0169	0.0592	CbGbCtD
Fluphenazine—CYP2D6—Vinorelbine—lung cancer	0.016	0.0558	CbGbCtD
Fluphenazine—CYP1A2—Erlotinib—lung cancer	0.0149	0.052	CbGbCtD
Fluphenazine—ABCB1—Crizotinib—lung cancer	0.0135	0.0471	CbGbCtD
Fluphenazine—ABCB1—Gemcitabine—lung cancer	0.0132	0.0461	CbGbCtD
Fluphenazine—ABCB1—Erlotinib—lung cancer	0.013	0.0455	CbGbCtD
Fluphenazine—CYP2D6—Erlotinib—lung cancer	0.0122	0.0428	CbGbCtD
Fluphenazine—ABCB1—Paclitaxel—lung cancer	0.0119	0.0416	CbGbCtD
Fluphenazine—ABCB1—Irinotecan—lung cancer	0.0117	0.0411	CbGbCtD
Fluphenazine—CYP1A2—Etoposide—lung cancer	0.0108	0.0376	CbGbCtD
Fluphenazine—ABCB1—Vinblastine—lung cancer	0.0104	0.0365	CbGbCtD
Fluphenazine—CYP2D6—Vinblastine—lung cancer	0.00983	0.0344	CbGbCtD
Fluphenazine—ABCB1—Cisplatin—lung cancer	0.00957	0.0335	CbGbCtD
Fluphenazine—ABCB1—Etoposide—lung cancer	0.0094	0.0329	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—lung cancer	0.0086	0.0301	CbGbCtD
Fluphenazine—HTR2A—phrenic nerve—lung cancer	0.00832	0.222	CbGeAlD
Fluphenazine—ABCB1—Doxorubicin—lung cancer	0.00641	0.0224	CbGbCtD
Fluphenazine—ABCB1—Methotrexate—lung cancer	0.00621	0.0217	CbGbCtD
Fluphenazine—CYP2D6—Doxorubicin—lung cancer	0.00604	0.0211	CbGbCtD
Fluphenazine—HTR2A—pulmonary artery—lung cancer	0.00302	0.0806	CbGeAlD
Fluphenazine—CALM3—mammary gland—lung cancer	0.0016	0.0427	CbGeAlD
Fluphenazine—CALM1—mammary gland—lung cancer	0.00125	0.0334	CbGeAlD
Fluphenazine—CALM3—bronchus—lung cancer	0.000879	0.0234	CbGeAlD
Fluphenazine—CALM2—respiratory system—lung cancer	0.000838	0.0223	CbGeAlD
Fluphenazine—CALM1—respiratory system—lung cancer	0.000834	0.0222	CbGeAlD
Fluphenazine—CALM3—trachea—lung cancer	0.000789	0.021	CbGeAlD
Fluphenazine—DRD2—respiratory system—lung cancer	0.000771	0.0205	CbGeAlD
Fluphenazine—CALM3—cardiac atrium—lung cancer	0.000741	0.0198	CbGeAlD
Fluphenazine—CALM2—epithelium—lung cancer	0.000701	0.0187	CbGeAlD
Fluphenazine—CALM1—epithelium—lung cancer	0.000697	0.0186	CbGeAlD
Fluphenazine—CALM2—bronchus—lung cancer	0.00069	0.0184	CbGeAlD
Fluphenazine—CALM1—bronchus—lung cancer	0.000687	0.0183	CbGeAlD
Fluphenazine—CYP1A2—respiratory system—lung cancer	0.00065	0.0173	CbGeAlD
Fluphenazine—CALM3—bone marrow—lung cancer	0.000626	0.0167	CbGeAlD
Fluphenazine—CALM2—trachea—lung cancer	0.000619	0.0165	CbGeAlD
Fluphenazine—CALM1—trachea—lung cancer	0.000617	0.0164	CbGeAlD
Fluphenazine—HRH1—respiratory system—lung cancer	0.000609	0.0162	CbGeAlD
Fluphenazine—CYP2E1—respiratory system—lung cancer	0.000585	0.0156	CbGeAlD
Fluphenazine—CALM2—cardiac atrium—lung cancer	0.000582	0.0155	CbGeAlD
Fluphenazine—CALM1—cardiac atrium—lung cancer	0.000579	0.0154	CbGeAlD
Fluphenazine—CALM3—lung—lung cancer	0.000567	0.0151	CbGeAlD
Fluphenazine—HRH1—epithelium—lung cancer	0.000509	0.0136	CbGeAlD
Fluphenazine—HTR2A—respiratory system—lung cancer	0.000508	0.0136	CbGeAlD
Fluphenazine—ADRA2A—bronchus—lung cancer	0.000492	0.0131	CbGeAlD
Fluphenazine—CALM2—bone marrow—lung cancer	0.000491	0.0131	CbGeAlD
Fluphenazine—CALM1—bone marrow—lung cancer	0.000489	0.013	CbGeAlD
Fluphenazine—HRH1—trachea—lung cancer	0.00045	0.012	CbGeAlD
Fluphenazine—CALM2—lung—lung cancer	0.000445	0.0119	CbGeAlD
Fluphenazine—CALM1—lung—lung cancer	0.000443	0.0118	CbGeAlD
Fluphenazine—ADRA2A—trachea—lung cancer	0.000442	0.0118	CbGeAlD
Fluphenazine—HTR2A—epithelium—lung cancer	0.000425	0.0113	CbGeAlD
Fluphenazine—ADRA2A—cardiac atrium—lung cancer	0.000415	0.0111	CbGeAlD
Fluphenazine—DRD2—lung—lung cancer	0.000409	0.0109	CbGeAlD
Fluphenazine—CALM3—lymph node—lung cancer	0.000388	0.0103	CbGeAlD
Fluphenazine—HTR2A—trachea—lung cancer	0.000376	0.01	CbGeAlD
Fluphenazine—CYP1A2—lung—lung cancer	0.000345	0.0092	CbGeAlD
Fluphenazine—ABCB1—respiratory system—lung cancer	0.000333	0.00888	CbGeAlD
Fluphenazine—Cardiac arrest—Etoposide—lung cancer	0.000326	0.00269	CcSEcCtD
Fluphenazine—Leukopenia—Vinblastine—lung cancer	0.000324	0.00267	CcSEcCtD
Fluphenazine—HRH1—lung—lung cancer	0.000323	0.00862	CbGeAlD
Fluphenazine—Angioedema—Topotecan—lung cancer	0.000321	0.00265	CcSEcCtD
Fluphenazine—Cardiac arrest—Paclitaxel—lung cancer	0.00032	0.00263	CcSEcCtD
Fluphenazine—Pneumonia—Irinotecan—lung cancer	0.000319	0.00263	CcSEcCtD
Fluphenazine—ADRA2A—lung—lung cancer	0.000317	0.00846	CbGeAlD
Fluphenazine—Leukopenia—Topotecan—lung cancer	0.000315	0.00259	CcSEcCtD
Fluphenazine—Hypertension—Vinblastine—lung cancer	0.000313	0.00258	CcSEcCtD
Fluphenazine—Pneumonia—Gemcitabine—lung cancer	0.000311	0.00256	CcSEcCtD
Fluphenazine—Nausea—Crizotinib—lung cancer	0.000311	0.00256	CcSEcCtD
Fluphenazine—CYP2E1—lung—lung cancer	0.000311	0.00828	CbGeAlD
Fluphenazine—Urticaria—Teniposide—lung cancer	0.000308	0.00254	CcSEcCtD
Fluphenazine—Pancytopenia—Cisplatin—lung cancer	0.000307	0.00253	CcSEcCtD
Fluphenazine—Body temperature increased—Teniposide—lung cancer	0.000306	0.00252	CcSEcCtD
Fluphenazine—CALM2—lymph node—lung cancer	0.000304	0.00812	CbGeAlD
Fluphenazine—CALM1—lymph node—lung cancer	0.000303	0.00808	CbGeAlD
Fluphenazine—Erythema—Vinorelbine—lung cancer	0.000301	0.00248	CcSEcCtD
Fluphenazine—Dysphagia—Etoposide—lung cancer	0.000296	0.00244	CcSEcCtD
Fluphenazine—Blood disorder—Doxorubicin—lung cancer	0.000293	0.00242	CcSEcCtD
Fluphenazine—Liver injury—Doxorubicin—lung cancer	0.000291	0.0024	CcSEcCtD
Fluphenazine—Lethargy—Docetaxel—lung cancer	0.000291	0.0024	CcSEcCtD
Fluphenazine—Dysphagia—Paclitaxel—lung cancer	0.00029	0.00239	CcSEcCtD
Fluphenazine—Agranulocytosis—Gemcitabine—lung cancer	0.000289	0.00238	CcSEcCtD
Fluphenazine—Anaphylactic shock—Topotecan—lung cancer	0.000287	0.00237	CcSEcCtD
Fluphenazine—Hypersensitivity—Teniposide—lung cancer	0.000285	0.00235	CcSEcCtD
Fluphenazine—Nausea—Pemetrexed—lung cancer	0.000284	0.00234	CcSEcCtD
Fluphenazine—Nausea—Gefitinib—lung cancer	0.000282	0.00233	CcSEcCtD
Fluphenazine—Pancytopenia—Etoposide—lung cancer	0.000281	0.00232	CcSEcCtD
Fluphenazine—Skin disorder—Topotecan—lung cancer	0.000279	0.0023	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Doxorubicin—lung cancer	0.000279	0.0023	CcSEcCtD
Fluphenazine—ABCB1—epithelium—lung cancer	0.000278	0.00742	CbGeAlD
Fluphenazine—Skin disorder—Erlotinib—lung cancer	0.000276	0.00227	CcSEcCtD
Fluphenazine—Pancytopenia—Paclitaxel—lung cancer	0.000276	0.00227	CcSEcCtD
Fluphenazine—Angioedema—Vinorelbine—lung cancer	0.000275	0.00227	CcSEcCtD
Fluphenazine—Pruritus—Teniposide—lung cancer	0.000274	0.00226	CcSEcCtD
Fluphenazine—Oedema peripheral—Gemcitabine—lung cancer	0.000274	0.00225	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Paclitaxel—lung cancer	0.00027	0.00222	CcSEcCtD
Fluphenazine—HTR2A—lung—lung cancer	0.00027	0.0072	CbGeAlD
Fluphenazine—Leukopenia—Vinorelbine—lung cancer	0.000269	0.00222	CcSEcCtD
Fluphenazine—Pneumonia—Etoposide—lung cancer	0.000266	0.00219	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Paclitaxel—lung cancer	0.000265	0.00218	CcSEcCtD
Fluphenazine—Dyskinesia—Doxorubicin—lung cancer	0.000261	0.00215	CcSEcCtD
Fluphenazine—Pneumonia—Paclitaxel—lung cancer	0.00026	0.00215	CcSEcCtD
Fluphenazine—Hypertension—Vinorelbine—lung cancer	0.00026	0.00214	CcSEcCtD
Fluphenazine—Decreased appetite—Vinblastine—lung cancer	0.000257	0.00212	CcSEcCtD
Fluphenazine—Dyspnoea—Topotecan—lung cancer	0.000256	0.00211	CcSEcCtD
Fluphenazine—Urine output increased—Methotrexate—lung cancer	0.000256	0.00211	CcSEcCtD
Fluphenazine—Dyspnoea—Erlotinib—lung cancer	0.000253	0.00209	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—lung cancer	0.000253	0.00209	CcSEcCtD
Fluphenazine—Constipation—Vinblastine—lung cancer	0.000253	0.00208	CcSEcCtD
Fluphenazine—Decreased appetite—Topotecan—lung cancer	0.00025	0.00206	CcSEcCtD
Fluphenazine—Decreased appetite—Erlotinib—lung cancer	0.000247	0.00203	CcSEcCtD
Fluphenazine—Agranulocytosis—Etoposide—lung cancer	0.000246	0.00203	CcSEcCtD
Fluphenazine—Dysphagia—Docetaxel—lung cancer	0.000246	0.00203	CcSEcCtD
Fluphenazine—ABCB1—trachea—lung cancer	0.000246	0.00656	CbGeAlD
Fluphenazine—Anaphylactic shock—Vinorelbine—lung cancer	0.000246	0.00202	CcSEcCtD
Fluphenazine—Constipation—Topotecan—lung cancer	0.000245	0.00202	CcSEcCtD
Fluphenazine—Hepatocellular injury—Doxorubicin—lung cancer	0.000245	0.00202	CcSEcCtD
Fluphenazine—Constipation—Erlotinib—lung cancer	0.000243	0.002	CcSEcCtD
Fluphenazine—Headache—Teniposide—lung cancer	0.000243	0.002	CcSEcCtD
Fluphenazine—Abnormal dreams—Doxorubicin—lung cancer	0.000242	0.00199	CcSEcCtD
Fluphenazine—Erythema—Gemcitabine—lung cancer	0.000242	0.00199	CcSEcCtD
Fluphenazine—Tachycardia—Vinorelbine—lung cancer	0.00024	0.00197	CcSEcCtD
Fluphenazine—Muscle spasms—Irinotecan—lung cancer	0.000239	0.00197	CcSEcCtD
Fluphenazine—Skin disorder—Vinorelbine—lung cancer	0.000239	0.00197	CcSEcCtD
Fluphenazine—Salivary hypersecretion—Doxorubicin—lung cancer	0.000238	0.00196	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—lung cancer	0.000234	0.00193	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—lung cancer	0.000234	0.00193	CcSEcCtD
Fluphenazine—Pancytopenia—Docetaxel—lung cancer	0.000234	0.00193	CcSEcCtD
Fluphenazine—Nausea—Teniposide—lung cancer	0.00023	0.0019	CcSEcCtD
Fluphenazine—Hypotension—Vinorelbine—lung cancer	0.000229	0.00189	CcSEcCtD
Fluphenazine—Oedema peripheral—Paclitaxel—lung cancer	0.000229	0.00189	CcSEcCtD
Fluphenazine—Urticaria—Topotecan—lung cancer	0.000228	0.00188	CcSEcCtD
Fluphenazine—Body temperature increased—Topotecan—lung cancer	0.000227	0.00187	CcSEcCtD
Fluphenazine—Erythema—Cisplatin—lung cancer	0.000225	0.00186	CcSEcCtD
Fluphenazine—Body temperature increased—Erlotinib—lung cancer	0.000225	0.00185	CcSEcCtD
Fluphenazine—Renal failure acute—Methotrexate—lung cancer	0.000222	0.00183	CcSEcCtD
Fluphenazine—Leukopenia—Irinotecan—lung cancer	0.000222	0.00183	CcSEcCtD
Fluphenazine—HRH1—lymph node—lung cancer	0.000221	0.00589	CbGeAlD
Fluphenazine—Pneumonia—Docetaxel—lung cancer	0.000221	0.00182	CcSEcCtD
Fluphenazine—Dyspnoea—Vinorelbine—lung cancer	0.000219	0.0018	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinblastine—lung cancer	0.000218	0.00179	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000218	0.00179	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—lung cancer	0.000217	0.00579	CbGeAlD
Fluphenazine—Muscle spasms—Cisplatin—lung cancer	0.000217	0.00179	CcSEcCtD
Fluphenazine—Leukopenia—Gemcitabine—lung cancer	0.000216	0.00178	CcSEcCtD
Fluphenazine—Hypertension—Irinotecan—lung cancer	0.000214	0.00177	CcSEcCtD
Fluphenazine—Decreased appetite—Vinorelbine—lung cancer	0.000213	0.00176	CcSEcCtD
Fluphenazine—Vision blurred—Cisplatin—lung cancer	0.000212	0.00175	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000212	0.00175	CcSEcCtD
Fluphenazine—Hypersensitivity—Topotecan—lung cancer	0.000211	0.00174	CcSEcCtD
Fluphenazine—Constipation—Vinorelbine—lung cancer	0.00021	0.00173	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—lung cancer	0.000209	0.00173	CcSEcCtD
Fluphenazine—Hypertension—Gemcitabine—lung cancer	0.000209	0.00172	CcSEcCtD
Fluphenazine—Agranulocytosis—Docetaxel—lung cancer	0.000205	0.00169	CcSEcCtD
Fluphenazine—Pruritus—Topotecan—lung cancer	0.000203	0.00167	CcSEcCtD
Fluphenazine—Anaphylactic shock—Irinotecan—lung cancer	0.000203	0.00167	CcSEcCtD
Fluphenazine—Photosensitivity—Doxorubicin—lung cancer	0.000202	0.00167	CcSEcCtD
Fluphenazine—Erythema—Paclitaxel—lung cancer	0.000202	0.00167	CcSEcCtD
Fluphenazine—Leukopenia—Cisplatin—lung cancer	0.000202	0.00166	CcSEcCtD
Fluphenazine—Pruritus—Erlotinib—lung cancer	0.000201	0.00166	CcSEcCtD
Fluphenazine—Muscle spasms—Etoposide—lung cancer	0.000198	0.00164	CcSEcCtD
Fluphenazine—Eczema—Doxorubicin—lung cancer	0.000198	0.00163	CcSEcCtD
Fluphenazine—Anaphylactic shock—Gemcitabine—lung cancer	0.000197	0.00163	CcSEcCtD
Fluphenazine—ABCB1—bone marrow—lung cancer	0.000195	0.00521	CbGeAlD
Fluphenazine—Urticaria—Vinorelbine—lung cancer	0.000195	0.00161	CcSEcCtD
Fluphenazine—Muscle spasms—Paclitaxel—lung cancer	0.000195	0.0016	CcSEcCtD
Fluphenazine—Body temperature increased—Vinorelbine—lung cancer	0.000194	0.0016	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—lung cancer	0.000194	0.0016	CcSEcCtD
Fluphenazine—Renal failure acute—Doxorubicin—lung cancer	0.000193	0.00159	CcSEcCtD
Fluphenazine—Skin disorder—Gemcitabine—lung cancer	0.000192	0.00158	CcSEcCtD
Fluphenazine—Vision blurred—Paclitaxel—lung cancer	0.000191	0.00157	CcSEcCtD
Fluphenazine—Hypotension—Irinotecan—lung cancer	0.000189	0.00156	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000188	0.00155	CcSEcCtD
Fluphenazine—Agitation—Paclitaxel—lung cancer	0.000186	0.00153	CcSEcCtD
Fluphenazine—Headache—Vinblastine—lung cancer	0.000185	0.00153	CcSEcCtD
Fluphenazine—Angioedema—Paclitaxel—lung cancer	0.000185	0.00152	CcSEcCtD
Fluphenazine—Leukopenia—Etoposide—lung cancer	0.000185	0.00152	CcSEcCtD
Fluphenazine—Hypotension—Gemcitabine—lung cancer	0.000184	0.00152	CcSEcCtD
Fluphenazine—Anaphylactic shock—Cisplatin—lung cancer	0.000184	0.00152	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000184	0.00151	CcSEcCtD
Fluphenazine—Lethargy—Doxorubicin—lung cancer	0.000181	0.00149	CcSEcCtD
Fluphenazine—Leukopenia—Paclitaxel—lung cancer	0.000181	0.00149	CcSEcCtD
Fluphenazine—Hypersensitivity—Vinorelbine—lung cancer	0.000181	0.00149	CcSEcCtD
Fluphenazine—Dyspnoea—Irinotecan—lung cancer	0.000181	0.00149	CcSEcCtD
Fluphenazine—Somnolence—Irinotecan—lung cancer	0.00018	0.00148	CcSEcCtD
Fluphenazine—Headache—Topotecan—lung cancer	0.00018	0.00148	CcSEcCtD
Fluphenazine—Tachycardia—Cisplatin—lung cancer	0.000179	0.00148	CcSEcCtD
Fluphenazine—Skin disorder—Cisplatin—lung cancer	0.000179	0.00147	CcSEcCtD
Fluphenazine—Hypertension—Etoposide—lung cancer	0.000178	0.00147	CcSEcCtD
Fluphenazine—Headache—Erlotinib—lung cancer	0.000178	0.00147	CcSEcCtD
Fluphenazine—Asthma—Methotrexate—lung cancer	0.000177	0.00146	CcSEcCtD
Fluphenazine—ABCB1—lung—lung cancer	0.000177	0.00472	CbGeAlD
Fluphenazine—Decreased appetite—Irinotecan—lung cancer	0.000176	0.00145	CcSEcCtD
Fluphenazine—Dyspnoea—Gemcitabine—lung cancer	0.000176	0.00145	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—lung cancer	0.000176	0.00145	CcSEcCtD
Fluphenazine—Nausea—Vinblastine—lung cancer	0.000176	0.00145	CcSEcCtD
Fluphenazine—Somnolence—Gemcitabine—lung cancer	0.000175	0.00145	CcSEcCtD
Fluphenazine—Hypertension—Paclitaxel—lung cancer	0.000175	0.00144	CcSEcCtD
Fluphenazine—Pruritus—Vinorelbine—lung cancer	0.000174	0.00143	CcSEcCtD
Fluphenazine—Constipation—Irinotecan—lung cancer	0.000173	0.00143	CcSEcCtD
Fluphenazine—Hypotension—Cisplatin—lung cancer	0.000172	0.00142	CcSEcCtD
Fluphenazine—Erythema—Docetaxel—lung cancer	0.000172	0.00141	CcSEcCtD
Fluphenazine—Decreased appetite—Gemcitabine—lung cancer	0.000171	0.00141	CcSEcCtD
Fluphenazine—Nausea—Topotecan—lung cancer	0.000171	0.00141	CcSEcCtD
Fluphenazine—Cardiac arrest—Doxorubicin—lung cancer	0.000169	0.00139	CcSEcCtD
Fluphenazine—Constipation—Gemcitabine—lung cancer	0.000169	0.00139	CcSEcCtD
Fluphenazine—Nausea—Erlotinib—lung cancer	0.000169	0.00139	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—lung cancer	0.000169	0.00139	CcSEcCtD
Fluphenazine—Dry mouth—Paclitaxel—lung cancer	0.000169	0.00139	CcSEcCtD
Fluphenazine—Anaphylactic shock—Etoposide—lung cancer	0.000168	0.00139	CcSEcCtD
Fluphenazine—Anaphylactic shock—Paclitaxel—lung cancer	0.000165	0.00136	CcSEcCtD
Fluphenazine—Flupentixol—ABCB1—lung cancer	0.000165	0.13	CrCbGaD
Fluphenazine—Muscle spasms—Docetaxel—lung cancer	0.000165	0.00136	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—lung cancer	0.000165	0.00136	CcSEcCtD
Fluphenazine—Tachycardia—Etoposide—lung cancer	0.000164	0.00135	CcSEcCtD
Fluphenazine—Dyspnoea—Cisplatin—lung cancer	0.000164	0.00135	CcSEcCtD
Fluphenazine—Skin disorder—Etoposide—lung cancer	0.000164	0.00135	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—lung cancer	0.000162	0.00133	CcSEcCtD
Fluphenazine—Tachycardia—Paclitaxel—lung cancer	0.000161	0.00133	CcSEcCtD
Fluphenazine—Skin disorder—Paclitaxel—lung cancer	0.00016	0.00132	CcSEcCtD
Fluphenazine—Body temperature increased—Irinotecan—lung cancer	0.00016	0.00132	CcSEcCtD
Fluphenazine—Decreased appetite—Cisplatin—lung cancer	0.00016	0.00132	CcSEcCtD
Fluphenazine—Pneumonia—Methotrexate—lung cancer	0.000159	0.00131	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—lung cancer	0.000158	0.0013	CcSEcCtD
Fluphenazine—Hypotension—Etoposide—lung cancer	0.000157	0.0013	CcSEcCtD
Fluphenazine—Body temperature increased—Gemcitabine—lung cancer	0.000156	0.00129	CcSEcCtD
Fluphenazine—Hypotension—Paclitaxel—lung cancer	0.000154	0.00127	CcSEcCtD
Fluphenazine—Headache—Vinorelbine—lung cancer	0.000154	0.00127	CcSEcCtD
Fluphenazine—Dysphagia—Doxorubicin—lung cancer	0.000154	0.00127	CcSEcCtD
Fluphenazine—Asthma—Doxorubicin—lung cancer	0.000154	0.00127	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—lung cancer	0.000154	0.00127	CcSEcCtD
Fluphenazine—Eosinophilia—Doxorubicin—lung cancer	0.000152	0.00125	CcSEcCtD
Fluphenazine—Dyspnoea—Etoposide—lung cancer	0.00015	0.00124	CcSEcCtD
Fluphenazine—Somnolence—Etoposide—lung cancer	0.00015	0.00123	CcSEcCtD
Fluphenazine—Hypersensitivity—Irinotecan—lung cancer	0.000149	0.00123	CcSEcCtD
Fluphenazine—Hypertension—Docetaxel—lung cancer	0.000148	0.00122	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—lung cancer	0.000148	0.00122	CcSEcCtD
Fluphenazine—Dyspnoea—Paclitaxel—lung cancer	0.000147	0.00121	CcSEcCtD
Fluphenazine—Somnolence—Paclitaxel—lung cancer	0.000147	0.00121	CcSEcCtD
Fluphenazine—Decreased appetite—Etoposide—lung cancer	0.000146	0.00121	CcSEcCtD
Fluphenazine—Pancytopenia—Doxorubicin—lung cancer	0.000146	0.0012	CcSEcCtD
Fluphenazine—Nausea—Vinorelbine—lung cancer	0.000146	0.0012	CcSEcCtD
Fluphenazine—Body temperature increased—Cisplatin—lung cancer	0.000145	0.0012	CcSEcCtD
Fluphenazine—Constipation—Etoposide—lung cancer	0.000144	0.00119	CcSEcCtD
Fluphenazine—Decreased appetite—Paclitaxel—lung cancer	0.000144	0.00118	CcSEcCtD
Fluphenazine—Dry mouth—Docetaxel—lung cancer	0.000143	0.00118	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000143	0.00118	CcSEcCtD
Fluphenazine—Constipation—Paclitaxel—lung cancer	0.000141	0.00116	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Doxorubicin—lung cancer	0.00014	0.00116	CcSEcCtD
Fluphenazine—Anaphylactic shock—Docetaxel—lung cancer	0.00014	0.00115	CcSEcCtD
Fluphenazine—Pruritus—Gemcitabine—lung cancer	0.00014	0.00115	CcSEcCtD
Fluphenazine—Pneumonia—Doxorubicin—lung cancer	0.000138	0.00114	CcSEcCtD
Fluphenazine—Drowsiness—Doxorubicin—lung cancer	0.000137	0.00113	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—lung cancer	0.000137	0.00113	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—lung cancer	0.000136	0.00112	CcSEcCtD
Fluphenazine—Hypersensitivity—Cisplatin—lung cancer	0.000135	0.00112	CcSEcCtD
Fluphenazine—Urticaria—Etoposide—lung cancer	0.000134	0.0011	CcSEcCtD
Fluphenazine—Body temperature increased—Etoposide—lung cancer	0.000133	0.0011	CcSEcCtD
Fluphenazine—Urticaria—Paclitaxel—lung cancer	0.000131	0.00108	CcSEcCtD
Fluphenazine—Hypotension—Docetaxel—lung cancer	0.000131	0.00108	CcSEcCtD
Fluphenazine—Body temperature increased—Paclitaxel—lung cancer	0.000131	0.00108	CcSEcCtD
Fluphenazine—Agranulocytosis—Doxorubicin—lung cancer	0.000128	0.00105	CcSEcCtD
Fluphenazine—Headache—Irinotecan—lung cancer	0.000127	0.00105	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—lung cancer	0.000125	0.00103	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—lung cancer	0.000124	0.00103	CcSEcCtD
Fluphenazine—Hypersensitivity—Etoposide—lung cancer	0.000124	0.00102	CcSEcCtD
Fluphenazine—Erythema—Methotrexate—lung cancer	0.000124	0.00102	CcSEcCtD
Fluphenazine—Headache—Gemcitabine—lung cancer	0.000124	0.00102	CcSEcCtD
Fluphenazine—Decreased appetite—Docetaxel—lung cancer	0.000122	0.001	CcSEcCtD
Fluphenazine—Hypersensitivity—Paclitaxel—lung cancer	0.000122	0.001	CcSEcCtD
Fluphenazine—Oedema peripheral—Doxorubicin—lung cancer	0.000121	0.000998	CcSEcCtD
Fluphenazine—ABCB1—lymph node—lung cancer	0.000121	0.00323	CbGeAlD
Fluphenazine—Nausea—Irinotecan—lung cancer	0.00012	0.000991	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—lung cancer	0.00012	0.000987	CcSEcCtD
Fluphenazine—Pruritus—Etoposide—lung cancer	0.000119	0.000982	CcSEcCtD
Fluphenazine—Nausea—Gemcitabine—lung cancer	0.000117	0.000966	CcSEcCtD
Fluphenazine—Pruritus—Paclitaxel—lung cancer	0.000117	0.000963	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—lung cancer	0.000117	0.00096	CcSEcCtD
Fluphenazine—Thioridazine—CYP2E1—lung cancer	0.000114	0.0891	CrCbGaD
Fluphenazine—Body temperature increased—Docetaxel—lung cancer	0.000111	0.000912	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—lung cancer	0.000111	0.000912	CcSEcCtD
Fluphenazine—Nausea—Cisplatin—lung cancer	0.000109	0.0009	CcSEcCtD
Fluphenazine—Methotrimeprazine—CYP2E1—lung cancer	0.000108	0.0851	CrCbGaD
Fluphenazine—Erythema—Doxorubicin—lung cancer	0.000107	0.000882	CcSEcCtD
Fluphenazine—Headache—Etoposide—lung cancer	0.000106	0.00087	CcSEcCtD
Fluphenazine—Headache—Paclitaxel—lung cancer	0.000103	0.000853	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—lung cancer	0.000103	0.00085	CcSEcCtD
Fluphenazine—Muscle spasms—Doxorubicin—lung cancer	0.000103	0.000848	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—lung cancer	0.000101	0.000832	CcSEcCtD
Fluphenazine—Vision blurred—Doxorubicin—lung cancer	0.000101	0.000831	CcSEcCtD
Fluphenazine—Nausea—Etoposide—lung cancer	0.0001	0.000825	CcSEcCtD
Fluphenazine—Pruritus—Docetaxel—lung cancer	9.9e-05	0.000816	CcSEcCtD
Fluphenazine—Agitation—Doxorubicin—lung cancer	9.84e-05	0.000811	CcSEcCtD
Fluphenazine—Nausea—Paclitaxel—lung cancer	9.81e-05	0.000808	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—lung cancer	9.8e-05	0.000808	CcSEcCtD
Fluphenazine—Leukopenia—Doxorubicin—lung cancer	9.58e-05	0.00079	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—lung cancer	9.43e-05	0.000777	CcSEcCtD
Fluphenazine—Hypertension—Doxorubicin—lung cancer	9.24e-05	0.000762	CcSEcCtD
Fluphenazine—Nefazodone—ABCB1—lung cancer	9.22e-05	0.0724	CrCbGaD
Fluphenazine—Dyspnoea—Methotrexate—lung cancer	9e-05	0.000741	CcSEcCtD
Fluphenazine—Triflupromazine—ABCB1—lung cancer	8.99e-05	0.0705	CrCbGaD
Fluphenazine—Somnolence—Methotrexate—lung cancer	8.97e-05	0.000739	CcSEcCtD
Fluphenazine—Dry mouth—Doxorubicin—lung cancer	8.91e-05	0.000735	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—lung cancer	8.77e-05	0.000723	CcSEcCtD
Fluphenazine—Headache—Docetaxel—lung cancer	8.77e-05	0.000723	CcSEcCtD
Fluphenazine—Anaphylactic shock—Doxorubicin—lung cancer	8.74e-05	0.00072	CcSEcCtD
Fluphenazine—Acepromazine—ALB—lung cancer	8.72e-05	0.0684	CrCbGaD
Fluphenazine—Trazodone—ABCB1—lung cancer	8.53e-05	0.0669	CrCbGaD
Fluphenazine—Tachycardia—Doxorubicin—lung cancer	8.53e-05	0.000703	CcSEcCtD
Fluphenazine—Thioproperazine—ALB—lung cancer	8.52e-05	0.0668	CrCbGaD
Fluphenazine—Skin disorder—Doxorubicin—lung cancer	8.49e-05	0.000699	CcSEcCtD
Fluphenazine—Thiothixene—ALB—lung cancer	8.38e-05	0.0657	CrCbGaD
Fluphenazine—Pipotiazine—ALB—lung cancer	8.38e-05	0.0657	CrCbGaD
Fluphenazine—Nausea—Docetaxel—lung cancer	8.32e-05	0.000685	CcSEcCtD
Fluphenazine—Chlorpromazine—CYP2E1—lung cancer	8.27e-05	0.0649	CrCbGaD
Fluphenazine—Hypotension—Doxorubicin—lung cancer	8.16e-05	0.000673	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—lung cancer	8.02e-05	0.000661	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—lung cancer	7.98e-05	0.000657	CcSEcCtD
Fluphenazine—Dyspnoea—Doxorubicin—lung cancer	7.79e-05	0.000642	CcSEcCtD
Fluphenazine—Somnolence—Doxorubicin—lung cancer	7.77e-05	0.00064	CcSEcCtD
Fluphenazine—Decreased appetite—Doxorubicin—lung cancer	7.6e-05	0.000626	CcSEcCtD
Fluphenazine—Constipation—Doxorubicin—lung cancer	7.47e-05	0.000616	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—lung cancer	7.43e-05	0.000613	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—lung cancer	7.14e-05	0.000588	CcSEcCtD
Fluphenazine—Urticaria—Doxorubicin—lung cancer	6.94e-05	0.000572	CcSEcCtD
Fluphenazine—Body temperature increased—Doxorubicin—lung cancer	6.91e-05	0.000569	CcSEcCtD
Fluphenazine—Hypersensitivity—Doxorubicin—lung cancer	6.44e-05	0.00053	CcSEcCtD
Fluphenazine—Headache—Methotrexate—lung cancer	6.32e-05	0.000521	CcSEcCtD
Fluphenazine—Pruritus—Doxorubicin—lung cancer	6.18e-05	0.000509	CcSEcCtD
Fluphenazine—Nausea—Methotrexate—lung cancer	5.99e-05	0.000494	CcSEcCtD
Fluphenazine—Trifluoperazine—ABCB1—lung cancer	5.53e-05	0.0433	CrCbGaD
Fluphenazine—Headache—Doxorubicin—lung cancer	5.47e-05	0.000451	CcSEcCtD
Fluphenazine—Quetiapine—ABCB1—lung cancer	5.36e-05	0.042	CrCbGaD
Fluphenazine—Nausea—Doxorubicin—lung cancer	5.19e-05	0.000428	CcSEcCtD
Fluphenazine—Chlorpromazine—ALB—lung cancer	4.54e-05	0.0356	CrCbGaD
Fluphenazine—Chlorpromazine—ABCB1—lung cancer	4.34e-05	0.034	CrCbGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CB—lung cancer	2.5e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTEN—lung cancer	2.5e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTEN—lung cancer	2.5e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—PIK3CA—lung cancer	2.5e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—PIK3CA—lung cancer	2.5e-06	1.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—lung cancer	2.49e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MDM2—lung cancer	2.49e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MDM2—lung cancer	2.49e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EP300—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—EP300—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RAF1—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RAF1—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EP300—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.48e-06	1.53e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—PIK3CA—lung cancer	2.47e-06	1.52e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—EP300—lung cancer	2.46e-06	1.52e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SRC—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB2—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB2—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—JUN—lung cancer	2.45e-06	1.51e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—PIK3CA—lung cancer	2.44e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—lung cancer	2.44e-06	1.5e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—lung cancer	2.43e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—lung cancer	2.43e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MTOR—lung cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CB—lung cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MTOR—lung cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CB—lung cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—lung cancer	2.42e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SRC—lung cancer	2.41e-06	1.49e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SRC—lung cancer	2.41e-06	1.48e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—lung cancer	2.4e-06	1.48e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—lung cancer	2.39e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—lung cancer	2.39e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—lung cancer	2.39e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—EP300—lung cancer	2.38e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—EP300—lung cancer	2.38e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.38e-06	1.47e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.37e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—lung cancer	2.37e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.37e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—lung cancer	2.37e-06	1.46e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.36e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—lung cancer	2.36e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—lung cancer	2.36e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—PIK3CA—lung cancer	2.36e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—lung cancer	2.35e-06	1.45e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—lung cancer	2.35e-06	1.44e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—AKT1—lung cancer	2.35e-06	1.44e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—lung cancer	2.33e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—lung cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—lung cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—lung cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—lung cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—lung cancer	2.32e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—lung cancer	2.31e-06	1.43e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.31e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—lung cancer	2.31e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—lung cancer	2.31e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—lung cancer	2.3e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CASP3—lung cancer	2.3e-06	1.42e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—lung cancer	2.3e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—lung cancer	2.29e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—lung cancer	2.29e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—lung cancer	2.29e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—lung cancer	2.28e-06	1.41e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—PIK3CA—lung cancer	2.28e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—PIK3CA—lung cancer	2.28e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CB—lung cancer	2.27e-06	1.4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK3—lung cancer	2.26e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EP300—lung cancer	2.26e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—lung cancer	2.26e-06	1.39e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—POMC—lung cancer	2.25e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—lung cancer	2.25e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCND1—lung cancer	2.24e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—JUN—lung cancer	2.23e-06	1.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CASP3—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CASP3—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK3—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK3—lung cancer	2.22e-06	1.37e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—lung cancer	2.21e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—lung cancer	2.21e-06	1.36e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—lung cancer	2.2e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SRC—lung cancer	2.2e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CREBBP—lung cancer	2.19e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—lung cancer	2.19e-06	1.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—lung cancer	2.18e-06	1.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PIK3CA—lung cancer	2.18e-06	1.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—lung cancer	2.17e-06	1.34e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CDKN1A—lung cancer	2.17e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCND1—lung cancer	2.17e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCND1—lung cancer	2.17e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—JUN—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—JUN—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTEN—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—lung cancer	2.16e-06	1.33e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—lung cancer	2.15e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	2.14e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CB—lung cancer	2.14e-06	1.32e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—PIK3CA—lung cancer	2.13e-06	1.31e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—lung cancer	2.12e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—lung cancer	2.12e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—lung cancer	2.12e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—PIK3CA—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—AKT1—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PIK3CA—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PIK3CA—lung cancer	2.11e-06	1.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—lung cancer	2.1e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—lung cancer	2.1e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CDKN1A—lung cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CDKN1A—lung cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTEN—lung cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTEN—lung cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—lung cancer	2.09e-06	1.29e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CD—lung cancer	2.08e-06	1.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EP300—lung cancer	2.06e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—lung cancer	2.06e-06	1.27e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—lung cancer	2.05e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—lung cancer	2.05e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—AKT1—lung cancer	2.04e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—AKT1—lung cancer	2.04e-06	1.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—lung cancer	2.03e-06	1.25e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	2.02e-06	1.25e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—lung cancer	2.02e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—lung cancer	2.02e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—AKT1—lung cancer	2.02e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—lung cancer	2.01e-06	1.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SRC—lung cancer	2e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—lung cancer	2e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PIK3CA—lung cancer	2e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—lung cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EP300—lung cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EP300—lung cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—AKT1—lung cancer	1.99e-06	1.23e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.97e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—lung cancer	1.97e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTEN—lung cancer	1.96e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—lung cancer	1.96e-06	1.21e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—lung cancer	1.95e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—lung cancer	1.95e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—lung cancer	1.95e-06	1.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SRC—lung cancer	1.94e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SRC—lung cancer	1.94e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—lung cancer	1.93e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—lung cancer	1.93e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—lung cancer	1.93e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—AKT1—lung cancer	1.93e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.92e-06	1.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—lung cancer	1.89e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—lung cancer	1.89e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—lung cancer	1.88e-06	1.16e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—lung cancer	1.87e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—lung cancer	1.87e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—lung cancer	1.87e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—EP300—lung cancer	1.87e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—PIK3CA—lung cancer	1.87e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—AKT1—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—AKT1—lung cancer	1.86e-06	1.15e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK3—lung cancer	1.85e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTEN—lung cancer	1.85e-06	1.14e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—PIK3CA—lung cancer	1.84e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PIK3CA—lung cancer	1.83e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—PIK3CA—lung cancer	1.83e-06	1.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PIK3CA—lung cancer	1.82e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.82e-06	1.12e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.81e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—lung cancer	1.81e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—lung cancer	1.8e-06	1.11e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—lung cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK3—lung cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK3—lung cancer	1.79e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—AKT1—lung cancer	1.78e-06	1.1e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—lung cancer	1.78e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—lung cancer	1.77e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PIK3CA—lung cancer	1.76e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PIK3CA—lung cancer	1.76e-06	1.09e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—EP300—lung cancer	1.76e-06	1.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—lung cancer	1.76e-06	1.08e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—lung cancer	1.74e-06	1.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—lung cancer	1.74e-06	1.07e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—AKT1—lung cancer	1.74e-06	1.07e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—AKT1—lung cancer	1.73e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—lung cancer	1.73e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—AKT1—lung cancer	1.72e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—AKT1—lung cancer	1.72e-06	1.06e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—lung cancer	1.7e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—lung cancer	1.7e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—lung cancer	1.7e-06	1.05e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—lung cancer	1.7e-06	1.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.67e-06	1.03e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—lung cancer	1.66e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—lung cancer	1.65e-06	1.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—AKT1—lung cancer	1.63e-06	1.01e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—lung cancer	1.63e-06	1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—lung cancer	1.62e-06	9.99e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.62e-06	9.95e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—lung cancer	1.6e-06	9.89e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—lung cancer	1.6e-06	9.89e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTEN—lung cancer	1.56e-06	9.63e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.55e-06	9.52e-06	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—AKT1—lung cancer	1.52e-06	9.39e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PIK3CA—lung cancer	1.52e-06	9.39e-06	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—AKT1—lung cancer	1.5e-06	9.24e-06	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—AKT1—lung cancer	1.5e-06	9.23e-06	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—AKT1—lung cancer	1.5e-06	9.22e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—EP300—lung cancer	1.49e-06	9.18e-06	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—AKT1—lung cancer	1.49e-06	9.17e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.48e-06	9.11e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—lung cancer	1.47e-06	9.08e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	9.08e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	9.08e-06	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—AKT1—lung cancer	1.44e-06	8.87e-06	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—AKT1—lung cancer	1.44e-06	8.87e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—lung cancer	1.43e-06	8.79e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—lung cancer	1.43e-06	8.79e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—lung cancer	1.41e-06	8.69e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PIK3CA—lung cancer	1.38e-06	8.51e-06	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.36e-06	8.41e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—lung cancer	1.36e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—lung cancer	1.36e-06	8.4e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—lung cancer	1.35e-06	8.31e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—lung cancer	1.31e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—lung cancer	1.31e-06	8.04e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.3e-06	8.02e-06	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—AKT1—lung cancer	1.25e-06	7.67e-06	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—AKT1—lung cancer	1.2e-06	7.42e-06	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—AKT1—lung cancer	1.2e-06	7.42e-06	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—AKT1—lung cancer	1.13e-06	6.95e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PIK3CA—lung cancer	1.1e-06	6.79e-06	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—AKT1—lung cancer	1.06e-06	6.55e-06	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—AKT1—lung cancer	9.01e-07	5.55e-06	CbGpPWpGaD
